Levin Jeremy I, Du Mila T
Wyeth Research, Pearl River, NY 10965, USA.
Drug Des Discov. 2003;18(4):123-6.
Sulfonamide hydroxamate derivatives of anthranilic acids are known to be potent inhibitors of cell-free TACE enzyme. However, compounds of this structural class with both high potency and high selectivity for TACE over matrix metalloproteinases (MMPs) are uncommon. Replacement of the sulfonamide functionality with an isosteric sulfonate ester has resulted in a series of sulfonate ester hydroxamates, 2a-e, with excellent activity against TACE and excellent selectivity over MMP-1 and MMP-13. Although compounds 2a-e possess good permeability in a PAMPA assay, they are only weakly active as inhibitors of lipopolysaccharide (LPS)-stimulated tumor necrosis factor (TNF) production in human monocytic THP-1 cells. Protein binding affinity also does not predict the lack of cellular activity for these analogs.
已知邻氨基苯甲酸的磺酰胺异羟肟酸衍生物是无细胞TACE酶的有效抑制剂。然而,这类对TACE具有高效力且对基质金属蛋白酶(MMP)具有高选择性的结构类化合物并不常见。用等排体磺酸酯取代磺酰胺官能团已产生了一系列磺酸酯异羟肟酸酯(2a - e),它们对TACE具有优异的活性,并且对MMP - 1和MMP - 13具有优异的选择性。尽管化合物2a - e在PAMPA测定中具有良好的渗透性,但它们作为脂多糖(LPS)刺激的人单核细胞THP - 1细胞中肿瘤坏死因子(TNF)产生的抑制剂仅有微弱活性。蛋白质结合亲和力也无法预测这些类似物缺乏细胞活性的情况。